好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Action Observation Training Increases Dynamic Functional Connectivity in Patients with Multiple Sclerosis
Neuro-rehabilitation
P5 - Poster Session 5 (5:30 PM-6:30 PM)
7-008

To assess whether Action Observation Training (AOT) modifies brain dynamic functional network connectivity (dFNC) in healthy controls (HC) and multiple sclerosis (MS) patients with right (R) upper limb impairment.

AOT facilitates motor functional recovery, possibly through a functional modulation of brain networks.

In this blind, controlled study, 87 R-handed subjects were randomized into 2 experimental groups (HC-AOT n=23; MS-AOT n=20) and 2 control groups (HC-C n=23; MS-C n=21). The 2-weeks training consisted of 10 sessions of 45 minutes. AOT-groups watched 3 daily-life actions videos alternated by their execution with the R hand; C-groups performed the same tasks watching landscape videos. At baseline (t0) and after 2 weeks (w2), resting state fMRI was obtained. Independent component analysis identified 41 FC networks. Between-group differences and dFNC changes over-time in each group were evaluated using a dynamic approach, i.e., assessing FC on small temporal segments using sliding windows, and then grouping FC correlation matrices into recurrent FC states.

After training, MS groups improved in right upper limb functions. Two recurrent FC states were detected: State1, showing strong inter-network connectivity; and State2, with weak inter-network connectivity. At t0, MS patients showed a consistent dFNC decrease vs HC, especially in State1, mainly involving basal ganglia, cerebellar and default mode networks (DMN), and some increase of dFNC of visual, executive and attention networks. DFNC was significantly increased over time in both MS groups, especially in State1, with more effects in MS-AOT than in MS-C, and an involvement of sensorimotor, visual, basal ganglia, DMN and attention networks. Conversely, HC-groups showed a decrease of dFNC at w2 vs t0, with a prevalent involvement of sensorimotor, basal ganglia, cerebellar and attention networks in HC-AOT, and of DMN and attention network in HC-C.

Two-weeks of AOT modulated dFNC of several functional networks in MS patients.

Authors/Disclosures
Claudio Cordani
PRESENTER
Claudio Cordani has nothing to disclose.
Paola Valsasina Paola Valsasina has nothing to disclose.
No disclosure on file
Alessandro Meani Alessandro Meani has nothing to disclose.
Paolo Preziosa (Ospedale San Raffaele) Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Federica Esposito Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care.
Mauro Comola No disclosure on file
Massimo Filippi, MD, FAAN (Ospedale San Raffaele, Neuroimaging Research Unit) Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Maria A. Rocca (Neuroimaging Research Unit) Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.